IRX4204
IRX4204 NSCLC 1 01 2015
Phase 1 small_molecule terminated
Quick answer
IRX4204 for Lung Cancer, Nonsmall Cell is a Phase 1 program (small_molecule) at IO Biotech with 1 ClinicalTrials.gov record(s).
Program details
- Company
- IO Biotech
- Indication
- Lung Cancer, Nonsmall Cell
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- terminated